IRIS
CORREALE, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.574
NA - Nord America 1.255
AS - Asia 428
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
AF - Africa 1
OC - Oceania 1
Totale 3.265
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.253
IE - Irlanda 642
SE - Svezia 363
CN - Cina 274
UA - Ucraina 270
IT - Italia 107
SG - Singapore 71
AT - Austria 51
IN - India 49
CZ - Repubblica Ceca 41
FI - Finlandia 36
TR - Turchia 29
DE - Germania 24
FR - Francia 20
GB - Regno Unito 10
NL - Olanda 3
CA - Canada 2
ES - Italia 2
EU - Europa 2
IR - Iran 2
JP - Giappone 2
PE - Perù 2
RU - Federazione Russa 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BR - Brasile 1
EG - Egitto 1
HK - Hong Kong 1
HR - Croazia 1
PL - Polonia 1
RO - Romania 1
Totale 3.265
Salva come PNG Salva come JPEG
Città #
Dublin 642
Nyköping 233
Chandler 187
Jacksonville 170
Ashburn 162
Dearborn 72
Nanjing 61
Princeton 61
Vienna 51
Singapore 48
New York 47
Wilmington 45
Beijing 39
Seattle 29
Brno 28
Boardman 27
Helsinki 25
Los Angeles 25
Nanchang 22
Pune 22
San Mateo 17
Rome 15
Tianjin 15
Des Moines 14
Munich 13
Olomouc 13
Guangzhou 11
Jiaxing 11
Shenyang 11
Foggia 9
Renton 8
Washington 8
Changsha 7
Hangzhou 7
Kunming 7
Lund 7
Palermo 7
Stevenage 7
Woodbridge 7
Ann Arbor 6
Gesualdo 6
Hebei 6
Jinan 6
Shanghai 6
Acerra 5
Bari 5
Ningbo 5
Shenzhen 5
Changchun 4
Lanzhou 4
Messina 4
Norwalk 4
Philadelphia 4
San Severo 4
Apricena 3
Bisceglie 3
Borås 3
Hefei 3
Martina Franca 3
Redwood City 3
Stimigliano 3
Taglio Di Po 3
Wuhan 3
Zhengzhou 3
Augusta 2
Dongyang 2
Fuzhou 2
Hanover 2
Hilden 2
Kolkata 2
Lima 2
Naples 2
New Delhi 2
Orange 2
Qingdao 2
Rockville 2
Taizhou 2
Tehran 2
Valle 2
Agordo 1
Altamura 1
Andria 1
Aprilia 1
Arzano 1
Benetutti 1
Bitonto 1
Cairo 1
Chengdu 1
Chongqing 1
Cirié 1
Clearwater 1
Dallas 1
Glasgow 1
Haikou 1
Hubert 1
Hunedoara 1
Jackson 1
Jinhua 1
Kilcoy 1
Latina 1
Totale 2.345
Salva come PNG Salva come JPEG
Nome #
Alcohol-induced cardiac disease 96
ABCB1 SNP rs4148738 modulation of apixaban interindividual variability 83
EXPRESS: Don't stop at first glance; pulmonary artery angiosarcoma mimicking chronic thromboembolic pulmonary hypertension 83
Tissue Doppler Imaging predicts central sleep apnea in patients with chronic heart failure: data from the Daunia Registry 81
Cardiopulmonary exercise test predicts right heart catheterization 80
Typical Takotsubo syndrome and McConnell's phenomenon: What else lies beneath? 79
Chronic thromboembolic pulmonary hypertension. 75
"PAFIYAMA" syndrome; further evidence on a novel clinical entity 74
Tako-Tsubo cardiomyopathy in a teen girl with pheochromocytoma. 73
Late onset of coronary vasospasm after administration of methyl-ergometrine for gynecologic bleeding. 73
Angiotensin-converting enzyme inhibitors, angiotensin II receptors antagonists, beta-blockers and ivabradine as supportive therapy in pulmonary hypertension: Drug safety and tolerability 73
Delirium in heart failure 71
Inferior ST-Elevation Acute Myocardial Infarction or an Inferior-Lead Brugada-like Electrocardiogram Pattern Associated With the Use of Pregabalin and Quetiapine? 69
Recurrent Tako-Tsubo cardiomyopathy apparently induced by opposite triggers 68
Direct oral anti-coagulants compared to vitamin-K antagonists in cardioversion of atrial fibrillation: an updated meta-analysis 68
Macitentan Use in a Neurofibromatosis Type 1 Patient With Pulmonary Hypertension and External Jugular Phlebectasia 67
Redefining biomarkers in heart failure 67
Liver disease and heart failure: Back and forth 67
Direct oral anticoagulants versus standard triple therapy in atrial fibrillation and PCI: meta-analysis 64
Malignancies and outcome in Takotsubo syndrome: a meta-analysis study on cancer and stress cardiomyopathy 62
Tako-Tsubo cardiomyopathy recurrence in an elderly woman firstly diagnosed with acute myocardial infarction: How many cold cases to be reclassified? 60
Fenofibrate and Dyslipidemia: Still a Place in Therapy? 60
COMPASS vs PEGASUS approach in a comparative budget impact analysis 59
HIV-associated pulmonary arterial hypertension: from bedside to the future 56
"ischemic" ST elevation in a woman with left ventricular hypertrophy 56
Biomarkers in cardiorenal syndrome 55
SAT0325 Nailfold capillaroscopic changes in patients with idiopathic and systemic sclerosis-related pulmonary arterial ipertension 54
Liver disease and heart failure: an uptodate 54
Influence of Heart Rate on Left and Right Ventricular Longitudinal Strain in Patients with Chronic Heart Failure 54
Echocardiographic score for prediction of pulmonary hypertension at catheterization: The Daunia Heart Failure Registry 53
Novel AKAP9 mutation and long QT syndrome in a patient with torsades des pointes 53
Advanced heart failure: non-pharmacological approach 52
Cardiac contractility modulation in left ventricular systolic dysfunction: trick or treat? 51
Tako-Tsubo cardiomyopathy or allergic acute coronary syndrome: that is the question. 50
Gastrointestinal bleeding and coagulation disorders in a patient with left-ventricular assist device 47
Sacubitril/valsartan improves right ventricular function in a real-life population of patients with chronic heart failure: The Daunia Heart Failure Registry 46
Predictors of clinical improvement with sacubitril/valsartan in a real world population with chronic heart failure 46
Switch to SGLT2 Inhibitors and Improved Endothelial Function in Diabetic Patients with Chronic Heart Failure 46
Hospitalization cost reduction with sacubitril-valsartan implementation in a cohort of patients from the Daunia Heart Failure Registry 45
Drug-Induced Pulmonary Arterial Hypertension: Mechanisms and Clinical Management 44
Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: Where do we stand? 44
The thromboembolism in COVID-19: the unsolved problem 44
Brain Natriuretic Peptide Biomarkers in Current Clinical and Therapeutic Scenarios of Heart Failure 43
Direct oral anticoagulants more effective than low-molecular-weight heparin for venous thrombo-embolism in cancer: an updated meta-analysis of randomized trials 41
The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic 41
Chronic thromboembolic pulmonary hypertension mimicking coronary artery disease 40
ABCB1 SNP rs4148738 modulation of apixaban interindividual variability 39
Disease-modifier Drugs in Patients with Advanced Heart Failure: How to Optimize Their Use? 39
Remodelling is inversely proportional to left ventricular dimensions in a real-life population of patients with chronic heart failure after therapy with sacubitril/valsartan 39
Ventilatory power, a cardiopulmonary exercise testing parameter for the prediction of pulmonary hypertension at right heart catheterization 38
Switch to direct anticoagulants and improved endothelial function in patients with chronic heart failure and atrial fibrillation 38
Predictors of right ventricular function improvement with sacubitril/valsartan in a real-life population of patients with chronic heart failure 38
New Targets in Heart Failure Drug Therapy 38
Delirium in heart failure 35
Direct oral anticoagulants more effective than low-molecular-weight heparin for venous thrombo-embolism in cancer: an updated meta-analysis of randomized trials 35
Pharmacological Anti-Remodelling Effects of Disease-Modifying Drugs in Heart Failure with Reduced Ejection Fraction 34
Infection, atherothrombosis and thromboembolism beyond the COVID-19 disease: what similar in physiopathology and researches 34
Meta-analysis study on direct oral anticoagulants vs warfarin therapy in atrial fibrillation and PCI: Dual or triple approach? 33
Lower Major Bleeding Rates with Direct Oral Anticoagulants in Catheter Ablation of Atrial Fibrillation: an Updated Meta-analysis of Randomized Controlled Studies 30
Meta-analysis study on direct oral anticoagulants vs warfarin therapy in atrial fibrillation and PCI: Dual or triple approach? 30
Survival of patients with idiopathic pulmonary fibrosis and pulmonary hypertension under therapy with nintedanib or pirfenidone 30
Effects of Sacubitril/Valsartan on the Renal Resistance Index 25
Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension 22
Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients 21
LEAP Virtual Visit Assessment (VIVA): A structured protocol for virtual visits for patients with heart failure 19
Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL.IT Study) 16
Optimization of Drug Therapy for Heart Failure With Reduced Ejection Fraction Based on Gender 16
Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan 14
Flow Mediated Dilation in Systemic Sclerosis: Association with clinical findings, capillaroscopic patterns and endothelial circulating markers 14
SGLT2 Inhibitors: Statins or ACE-Inhibitors of the 21st Century? 12
Atrial paced rhythm and heart rate-dependent worsening of left atrial and ventricular function 11
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register 8
Does the Measurement of Ejection Fraction Still Make Sense in the HFpEF Framework? What Recent Trials Suggest 7
Short-term anti-remodeling effects of gliflozins in diabetic patients with heart failure and reduced ejection fraction: an explainable artificial intelligence approach 7
Arrhythmic Risk Stratification among Patients with Hypertrophic Cardiomyopathy 6
Relationship between the strain measures of left atrial function and heart failure worsening 6
The Role of Congestion Biomarkers in Heart Failure with Reduced Ejection Fraction 6
Improvement in Left and Right Ventricular Function after Introduction of SGLT2 Inhibitors in Heart Failure Outpatients with Reduced Ejection Fraction 6
Switch to Gliflozins and Biventricular Function Improvement in Patients with Chronic Heart Failure and Diabetes Mellitus 6
Effect of sacubitril/valsartan on cardiac remodeling compared with other renin–angiotensin system inhibitors: a difference-in-difference analysis of propensity-score matched samples 5
Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic Registry 5
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan 5
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension 5
Introduction of SGLT2 Inhibitors and Variations in Other Disease-Modifying Drugs in Heart Failure Patients: A Single-Centre Real-World Experience 5
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study 5
Novelties in the pharmacological approaches for chronic heart failure: new drugs and cardiovascular targets 4
Imaging Modality to Guide Left Atrial Appendage Closure: Current Status and Future Perspectives 4
Alcohol consumption and subclinical and clinical coronary heart disease: New insight into potential causal mechanisms 4
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner? 4
Rationale and design of the Biventricular Evaluation of Gliflozins effects In chroNic Heart Failure: BEGIN-HF study 3
Efficacy of new medical therapies in patients with heart failure, reduced ejection fraction, and chronic kidney disease already receiving neurohormonal inhibitors: a network meta-analysis 3
Totale 3.571
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.705
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.705
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020314 0 28 6 2 40 51 67 9 50 14 44 3
2020/2021371 50 7 42 12 43 3 51 54 52 56 1 0
2021/2022412 17 2 11 3 70 14 11 38 49 86 6 105
2022/20231.331 117 69 83 38 31 104 2 86 702 10 40 49
2023/2024585 57 18 39 19 79 124 13 94 1 11 14 116
2024/2025106 88 18 0 0 0 0 0 0 0 0 0 0
Totale 3.571